Maze expects to close out 2020 with a headcount of 60, putting it ahead of its hiring plans. The team is currently working out of biotech hotspot The Cove At Oyster Point but has signed a lease on another site that will house up to 200 people. ...
AliosandAcerta. But lately I’ve noticed a different life sciences investing strategy, one closer to the way social/mobile/software investors invest. By paying higher entry prices for later mega-rounds in ambitious life sciences companies, including both therapeutics ...
Pharmaceutical and Biotechnology companies are exposed to more than their fair share of ESG risks, that, if not addressed properly, can have significant financial and reputational impacts in the long run. To measure a company’s level of exposure with industry-specific material ESG risks and how ...